Leveraging Viruses for the Treatment of Viral Diseases and Cancer: Improving Host Fitness by Combinations of Virus and Host Genes gives a comprehensive overview about the impact of using naturally or intentionally attenuated viruses, which are apathogenic to people, to control viral diseases and cancer. The book examines the potential of exploiting, developing, and using of apathogenic viruses as therapeutic tool against viral diseases and cancer. It specifically covers the COVID-19 pandemic and the need for a post-Infection Plan B to combat SARS-CoV-2 infections as gaps in testing and vaccination create the perfect conditions for a new variant of concern to emerge which could cause significant mortality thus demonstrating a need for further research for inexpensive and effective therapies. More generally, the book also provides specific examples of the use of apathogenic viruses to treat other infectious diseases. It discusses the process of manufacturing viral therapies and how infectious disease treatments can be repurposed to improve other therapies like for cancer. With contribution from an international group of contributors, Leveraging Viruses for the Treatment of Viral Diseases and Cancer is useful references for those engages in study and development of infectious diseases and ways to combat them.

• Discusses the development and application of virus-based therapy against cancer
• Covers the safety and potential drawbacks or side-effects of the use of apathogenic viruses as therapeutic agents
• Explores the use of viruses to treat future (newly emerging) viruses